[Series] Harnessing genomics to improve outcomes for women with cancer in India: key priorities for research

Cumulatively, breast, cervical, ovarian, and uterine cancer account for more than 70% of cancers in women in India. Distinct differences in the clinical presentation of women with cancer suggest underlying differences in cancer biology and genetics. The peak age of onset of breast and ovarian cancer appears to be a decade earlier in India (age 45 –50 years) than in high-income countries (age>60 years). Understanding these differences through research to develop diagnosis, screening, prevention, and treatment frameworks that ar e specific to the Indian population are critical and essential to improving women's health in India.

Source: The Lancet Oncology - February 1, 2018 Category: Cancer & Oncology Authors: Sudha Sundar, Poonam Khetrapal-Singh, Jon Frampton, Edward Trimble, Preetha Rajaraman, Ravi Mehrotra, Roopa Hariprasad, Arindam Maitra, Paramjit Gill, Vanita Suri, Radhika Srinivasan, Gurpreet Singh, J S Thakur, Preet Dhillon, Jean-Baptiste Cazier Tags: Series Source Type: research